title: Archimedes: Does caffeine treatment for apnoea of prematurity improve neurodevelopmental outcome in later life?
authors.affiliation: Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
authors.forename: Barbara
authors.initials: B
authors.lastname: Schmidt
authors.forename: Robin S
authors.initials: RS
authors.lastname: Roberts
authors.forename: Peter
authors.initials: P
authors.lastname: Davis
authors.forename: Lex W
authors.initials: LW
authors.lastname: Doyle
mesh_terms: D001049:Apnea / Q000188:drug therapy* / Q000523:psychology; D002110:Caffeine / Q000627:therapeutic use*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002658:Developmental Disabilities / Q000517:prevention & control*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000188:drug therapy* / Q000523:psychology; D012107:Research Design
chemical_list: D000697:Central Nervous System Stimulants; D002110:Caffeine